MeSH tree: D27.505.954.502
Immunology and Infectious Disease Researcher and Senior Lecturer Dr. Hillary Vanderven is working against the clock with World Health Organization (WHO) experts reporting the next flu pandemic is a matter of when, not if.
May 31, 2024
0
30
Urinary catheters are required for nearly every surgical procedure. However, a major challenge for the health care industry is predicting who may develop catheter-associated urinary tract infections (CAUTIs) and when these ...
May 30, 2024
0
31
Currently available flu medications only target the virus after it has already established an infection, but what if a drug could prevent infection in the first place? Now, scientists at Scripps Research and the Albert Einstein ...
May 21, 2024
0
57
Nature gave ticks, mosquitoes and leeches a quick-acting way to keep blood from clotting while they extract their meal from a host. Now the key to that method has been harnessed by a team of Duke researchers as a potential ...
May 13, 2024
0
56
Duke researchers have opened a new avenue in the attack against influenza viruses by creating a vaccine that encourages the immune system to target a portion of the virus surface that is less variable.
May 1, 2024
0
51
Researchers at the University of Sydney and University of Geneva have developed a new anticoagulant, whose anticlotting action can be rapidly stopped "on demand." The result could lead to new surgical and post-operative drugs ...
Apr 30, 2024
0
36
Recombinant protein vaccines, like the Novavax vaccine used to fight COVID-19, offer several advantages over conventional vaccines. They're easy to produce precisely. They're safe and potentially more effective. And they ...
Feb 23, 2024
0
98
Researchers have shed new light on how viral evolution, population immunity, and the co-circulation of other flu viruses shape seasonal flu epidemics.
Feb 13, 2024
0
68
In patients who undergo pulmonary resection for lung cancer, a major potential postoperative complication is venous thromboembolism (VTE)—a condition that develops when a blood clot forms in a vein—which can lead to part ...
Jan 29, 2024
0
39
An experimental drug designed to block blood-clotting proteins may lower the risk of recurrent strokes, according to a dose-finding trial published in The Lancet Neurology.
Jan 25, 2024
0
53
